VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Crinetics Pharmaceuticals, Inc. (CRNX) Total Return Calculator with Dividends Reinvested

Crinetics Pharmaceuticals, Inc.

Popular:

The total return for Crinetics Pharmaceuticals, Inc. (CRNX) stock is +38.50% over the past 12 months. So far it's down 6.97% this year. The 5-year total return is +156.34%, meaning $10,000 invested in CRNX stock 5 years ago would be worth $25,634 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in CRNX 1 year ago, it would be worth $13,295 today — you'd have gained $3,295.

With Dividends Reinvested$13,295+32.95%

Price Only (No DRIP)$13,295+32.95%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in CRNX

1Y$13,850+$3,850 (+38.5%)38.5% CAGR

3Y$19,734+$9,734 (+97.3%)25.4% CAGR

5Y$25,634+$15,634 (+156.3%)20.7% CAGR

10Y$17,738+$7,738 (+77.4%)5.9% CAGR

15Y$17,738+$7,738 (+77.4%)3.9% CAGR

20Y$17,738+$7,738 (+77.4%)2.9% CAGR

30Y$17,738+$7,738 (+77.4%)1.9% CAGR

Crinetics Pharmaceuticals, Inc. did not pay dividends during this period. Total return = price return.

Loading CRNX total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-6.97%	—	-6.97%	—	$9,303
1Y	+38.50%	38.50%	+38.50%	—	$13,850
3Y	+97.34%	25.43%	+97.34%	—	$19,734
5Y	+156.34%	20.72%	+156.34%	—	$25,634
10Y	+77.38%	5.90%	+77.38%	—	$17,738
15Y	+77.38%	3.89%	+77.38%	—	$17,738
20Y	+77.38%	2.91%	+77.38%	—	$17,738
30Y	+77.38%	1.93%	+77.38%	—	$17,738

Risk & Highlights

Best Year+103.66%2021

Worst Year-44.45%2020

Max Drawdown-40.33%2026-01-15 → 2026-03-27

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-12.05%	-12.05%	—	+0.41%	-12.5pp
2025	-9.70%	-9.70%	—	+16.64%	-26.3pp
2024	+44.48%	+44.48%	—	+24.00%	+20.5pp
2023	+96.57%	+96.57%	—	+24.81%	+71.8pp
2022	-35.36%	-35.36%	—	-19.95%	-15.4pp

CRNX outperformed the S&P 500 by 8.13pp over the past year (+38.50% vs +30.37%).

Loading summary...

CRNX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
CRNXCrinetics Pharmaceuticals, Inc.	$4.6B	+13.2%	-7.0%	+38.5%	—	+97.3%	+156.3%	+77.4%
RCUSArcus Biosciences, Inc.	$2.5B	+12.3%	+6.5%	+209.6%	—	+24.9%	-18.6%	+45.9%
CHRSCoherus Oncology, Inc.	$213M	+5.4%	+28.5%	+86.0%	—	-78.4%	-87.7%	-90.8%
ACVAACV Auctions Inc.	$1.1B	+40.4%	-21.6%	-58.6%	—	-51.3%	-80.4%	-79.2%
ACADACADIA Pharmaceuticals Inc.	$3.9B	+2.2%	-13.7%	+52.4%	—	+4.7%	+7.1%	-22.9%
NVAXNovavax, Inc.	$1.5B	+15.7%	+29.5%	+55.1%	—	+23.9%	-94.8%	-90.4%
ESPREsperion Therapeutics, Inc.	$653M	+35.9%	-15.4%	+260.5%	—	+132.6%	-85.9%	-79.6%
XNCRXencor, Inc.	$903M	+0.0%	-17.5%	+54.1%	—	-55.0%	-68.9%	+4.5%
PTCTPTC Therapeutics, Inc.	$5.3B	-7.3%	-16.0%	+58.2%	—	+16.1%	+60.3%	+733.2%
RAREUltragenyx Pharmaceutical Inc.	$2.6B	+12.9%	+10.7%	-21.8%	—	-44.5%	-77.2%	-59.4%
KRYSKrystal Biotech, Inc.	$8.7B	+12.4%	+20.2%	+116.9%	—	+238.5%	+319.2%	+2688.5%

Compare:CRNX vs RCUS CRNX vs CHRS CRNX vs ACVA CRNX vs RCUS vs CHRS

About CRNX Dividend Returns

Crinetics Pharmaceuticals, Inc. (CRNX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of CRNX over the past year?

Crinetics Pharmaceuticals, Inc. (CRNX) delivered a return of 38.50% over the past year. Since CRNX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in CRNX be worth today?

A $10,000 investment in Crinetics Pharmaceuticals, Inc. one year ago would be worth $13,850 today, representing a gain of $3,850.

Q3Does CRNX pay dividends?

Crinetics Pharmaceuticals, Inc. (CRNX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For CRNX, the total return equals the price-only return.

Q4Did CRNX beat the S&P 500?

Yes, Crinetics Pharmaceuticals, Inc. (CRNX) outperformed the S&P 500 by 8.13 percentage points over the past year. CRNX delivered a total return of 38.50%, compared to the S&P 500's 30.37%. This 8.13pp alpha means investors in CRNX earned more than a passive S&P 500 index fund.

Q5What is CRNX's worst drawdown?

Crinetics Pharmaceuticals, Inc. (CRNX) experienced a maximum drawdown of -40.33% over the past year, declining from its peak on 2026-01-15 to its trough on 2026-03-27. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is CRNX's long-term total return over 10, 20, or 30 years?

Here are Crinetics Pharmaceuticals, Inc. (CRNX)'s long-term returns with dividends reinvested. Over 10 years, the total return is 77.4% (5.9% CAGR) — $10,000 would have grown to $17,738. Over 20 years: 77.4% total return (2.9% CAGR) — $10,000 → $17,738. Over 30 years: 77.4% total return (1.9% CAGR) — $10,000 → $17,738. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was CRNX's best and worst year?

Crinetics Pharmaceuticals, Inc.'s best calendar year was 2021 with a total return of 103.7%. Its worst year was 2020 with a total return of -44.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 148.1 percentage points.